DENVER and PHOENIX, March 18, 2016 -- Dixie Brands, Inc. (Dixie), a leader in emerging cannabinoid extraction and wellness platforms, has launched the first phase of its joint venture with Bloom Dispensaries. The initial products available for sale today, includes the complete line of Dixie branded topical products as well as Dixie Brands' two new hemp-derived cannabinoid wellness platforms, Aceso a human wellness product line and Therabis, designed to serve pets. Dixie Brands Arizona will begin delivering these products to dispensaries throughout the state on March 21, 2016.
"Dixie is thrilled to deliver our full line of medical topicals, as well as our non-THC cannabinoid therapy products, to the patients in Arizona," said Tripp Keber, President and CEO of Dixie Brands, Inc. "Developed in Colorado, and powered by local Arizona grown cannabis, our three unique topical products combine THC with natural ingredients and organic oils to soothe and calm aches and pains from the skin, inward. Education about topicals and their benefits is a crucial element of this roll out as this product is ideal for patients who are looking for very effective pain relief without the euphoria or high normally associated with THC."
The initial launch will introduce Dixie's full topical product line, including their signature Relief Balm, Muscle Relief Lotion and Bath Soak. Developed over five years by Dixie's innovative science team in Colorado, these diverse topicals are a great way to treat localized skin irritation, joint pain and muscle aches.
"Today's announcement is the first of many milestones we expect to achieve as we work to bring the complete line of Dixie Elixirs and Edibles products to Arizona patients as quickly as our commercial state of the art manufacturing facility construction will allow," said Edward Judice, CEO of Bloom. "We view today's initial product launch as a great win for the Arizona medical marijuana community, who can benefit from the years of research and development that Dixie has invested in their products in order to deliver the product quality and consistency that Arizona patients deserve."
MSRP for the new products is as follows (but will vary by dispensary):
- Dixie 90MG Relief Balm: $14
- Dixie 90MG Pain Relief Lotion: $14
- Dixie 90MG Bath Soak: $16
|
|||||
Want to learn more about the benefits of topical THC uptake? Visit Dixie's Uptake System Education Page.
ABOUT DIXIE BRANDS, INC.
Located in Denver, Colorado, Dixie Brands, Inc., (Dixie) through its affiliates across the country, has been formulating and producing award-winning THC and CBD-infused products since 2009. What began as a single flagship product, the Dixie Elixir (a THC-infused soda), has now expanded to over 30 different products across over 100 SKUs, representing the industry's finest edibles, tinctures, topicals and connoisseur grade extractions. In addition, Dixie Brands has launched two new cannabinoid product lines: Aceso, is a suite of "hemp 2.0" products designed to provide general wellness and relief from minor aches and pains as well as mild-anxiety. Therabis is a pet supplement formulated by an experienced veterinarian and designed to provide pets, and their owners, with relief from itching and mild-anxiety as well as providing greater joint mobility. To find out more about Dixie's innovative products, or about how Dixie is building the future of cannabis, please visit us at http://www.dixiebrands.com.
CONTACT
Joe Hodas
Dixie Brands, Chief Marketing Officer
[email protected]
303-827-6972
A photo accompanying this release is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=39494
CONTACT: Joe Hodas
Dixie Brands, Chief Marketing Officer
[email protected]
303-827-6972


Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 



